View live charts, options flow & technicals for Elevance Health, Inc. →
Open Dashboard
Elevance Health, Inc. (ELV) is a healthcare company in the healthcare plans industry with $201.11B in trailing revenue trading at a 17.8× trailing P/E — analyst consensus: strong buy.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Key Statistics
Market Cap
$86.44B
Revenue (TTM)
$201.11B
EPS (TTM)
$22.40
EPS (Fwd est.)
$29.54
Employees
96,129
Trailing P/E
17.79
Forward P/E
13.49
PEG Ratio
1.32
Price / Sales
0.43
Price / Book
1.93
EV / EBITDA
9.62
Beta (5Y)
0.70
Analyst Consensus
Consensus
Strong Buy
Analyst Price Target
+13.3% upside
Target: $451.38
Annual Revenue & Net Income
RevenueNet Income
'22
$156.59B
$5.89B
'23
$171.34B
$5.99B
'24
$176.81B
$5.98B
'25
$199.12B
$5.66B
Earnings History
Quarter
Actual EPS
Estimate
Result
Jul 2026
$7.45
$6.21
Beat (+20.0%)
Apr 2026
$12.58
$10.81
Beat (+16.4%)
Jan 2026
$3.33
$3.09
Beat (+7.7%)
Oct 2025
$6.03
$4.94
Beat (+22.0%)
Next Earnings Report
Elevance Health, Inc. is next expected to report earnings on 21 Oct 2026.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad …
What is ELV's market cap?
Elevance Health, Inc. has a market capitalization of approximately $86.44B.
What is ELV's P/E ratio?
Elevance Health, Inc. trades at a trailing P/E ratio of 17.8x and a forward P/E of 13.5x, which is below the broad market average of ~25x.
How much revenue does ELV generate?
Elevance Health, Inc. generated $201.11B in trailing 12-month revenue.
What do analysts say about ELV?
The analyst consensus rating for Elevance Health, Inc. is strong buy, with a mean price target of $451.38. That implies +13.3% upside from the current price.
When does ELV report earnings?
Elevance Health, Inc. is next scheduled to report earnings on 21 Oct 2026.
Does ELV pay a dividend?
Yes. Elevance Health, Inc. pays a dividend with a current yield of 1.71%, at an annual rate of $6.88 per share.
View live charts, options flow, gamma exposure, earnings history, and technical analysis for Elevance Health, Inc. on Apsis Markets.